Hyogo Prefectural Cancer Center
In research, Hyogo Prefectural Cancer Center stands highest in Medicine (#5,210 of 10,443 worldwide) and Health Sciences (#6,930 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 14.9× its share of world research.
- World rank, 2022–2025
- #18,753 of 28,054 · #24,115 all time
- Rank in Japan
- #522 of 1,070
- Research works
- 597 ▲ 17% vs 2013–17
- Citations
- 7.7k 12.9 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 52% world 28%
What is Hyogo Prefectural Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,210 of 10,443 | 9.0% | 108 | #6540 | |
| Health SciencesDomain | #6,930 of 11,982 | 8.9% | 109 | #8771 |
Each strip is that field’s whole ranked pool, with the notch where Hyogo Prefectural Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Hyogo Prefectural Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.9× the share of its output that it takes of world research.
- OncologySubfield · 21.3 works15×
- Pulmonary and Respiratory MedicineSubfield · 25.7 works13×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
- Medicine 4.4×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Physics and Astronomy 0.8×
- Immunology and Microbiology 0.8×
- Veterinary 0.3×
- Health Professions 0.3×
- Economics, Econometrics and Finance 0.2×
- Materials Science 0.1×
- Neuroscience 0.1×
- Dentistry 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Chemistry 0.1×
- Arts and Humanities 0.1×
- Psychology 0.1×
- Computer Science 0.0×
- Mathematics 0.0×
- Social Sciences 0.0×
Who are the top researchers at Hyogo Prefectural Cancer Center?
Ranked on the composite score, Masahiro Tsuda, Shintaro Takao and Takashi Yamagishi lead among researchers whose main affiliation is Hyogo Prefectural Cancer Center.
- 1 Masahiro Tsuda Japan · #120,902 worldwide 167 citations · 38 works
- 2 Shintaro Takao Japan · #147,526 worldwide 256 citations · 48 works
- 3 Takashi Yamagishi Japan · #222,073 worldwide 119 citations · 26 works
- 4 Koji Matsumoto Japan · #403,293 worldwide 62 citations · 42 works
- 5 Ikuya Miki Japan · #520,999 worldwide 41 citations · 16 works
- 6 Shoji Nagao Japan · #521,687 worldwide 40 citations · 26 works
- 7 Satoshi Yamaguchi Japan · #630,222 worldwide 32 citations · 21 works
- 8 Miyako Satouchi Japan · #835,628 worldwide 50 citations · 48 works
- 9 Keisuke Goto Japan · #1,015,240 worldwide 15 citations · 21 works
- 10 Koichi Minato Japan · #1,115,337 worldwide 38 citations · 47 works
Which keywords describe research at Hyogo Prefectural Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Clinical Practice Guidelines, Prognostic Factors, Targeted Therapy, Clinical Trials, Immunotherapy and Adjuvant Therapy.
- Tumor Markers
- PET Imaging
- Human Papillomavirus
- Chemoradiation
- Immune Checkpoint Blockade
- Molecular Characterization
- Surgical Management
- ALK Inhibitors
- Biomarkers
- Precision Medicine
- Genomic Profiling
- Positron Emission Tomography
- Diagnosis
- Tumor Staging
- Neoadjuvant Therapy
- Tumor Microenvironment
- Immunotherapy
- Targeted Therapy
- Prognostic Factors
- Radiotherapy
- Chemotherapy
- Clinical Practice Guidelines
- Epidemiology
- Clinical Trials
- Adjuvant Therapy
- Survival Analysis
- Metastasis
- CT Screening
- Lung Cancer
- Treatment
- Endoscopic Resection
- Breast Cancer
- Management
- EGFR Mutations
- Treatment Guidelines
- Survival
- PD-1 and PD-L1
- Cervical Cancer
- Immunohistochemistry
- Preoperative Chemoradiotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy27▲ 31×22 topics
- Radiotherapy13▲ 26×12 topics
- Clinical Practice Guidelines12▲ 18×10 topics
- Prognostic Factors11▲ 20×14 topics
- Epidemiology10▲ 2.1×34 topics
- Targeted Therapy10▲ 33×4 topics
- Clinical Trials9▲ 11×5 topics
- Immunotherapy9▲ 10×17 topics
- Adjuvant Therapy9▲ 53×2 topics
- Tumor Microenvironment8▲ 15×6 topics
- Survival Analysis8▲ 22×6 topics
- Neoadjuvant Therapy7▲ 24×5 topics
- Metastasis7▲ 16×9 topics
- Tumor Staging6▲ 46×2 topics
- CT Screening6▲ 72×1 topic
- Diagnosis6▲ 5.1×16 topics
- Lung Cancer6▲ 28×2 topics
- Positron Emission Tomography6▲ 72×1 topic
- Treatment6▲ 4.0×17 topics
- Genomic Profiling6▲ 42×2 topics
- Endoscopic Resection5▲ 41×2 topics
- Precision Medicine5▲ 8.5×5 topics
- Breast Cancer5▲ 17×9 topics
- Biomarkers5▲ 5.6×8 topics
- Management5▲ 5.0×10 topics
- ALK Inhibitors5▲ 61×1 topic
- EGFR Mutations5▲ 61×1 topic
- Surgical Management5▲ 9.1×13 topics
- Treatment Guidelines5▲ 18×2 topics
- Molecular Characterization4▲ 19×5 topics
- Survival4▲ 26×3 topics
- Immune Checkpoint Blockade4▲ 31×1 topic
- PD-1 and PD-L14▲ 31×1 topic
- Chemoradiation4▲ 48×2 topics
- Cervical Cancer4▲ 27×2 topics
- Human Papillomavirus4▲ 23×3 topics
- Immunohistochemistry4▲ 39×4 topics
- PET Imaging4▲ 17×4 topics
- Preoperative Chemoradiotherapy4▲ 36×2 topics
- Tumor Markers3▲ 33×2 topics
Which research topics does Hyogo Prefectural Cancer Center publish most on?
By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Esophageal Cancer Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 6 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 4 Esophageal Cancer Research and Treatment Surgery 3 works
- 5 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 2 works
- 6 Lung Cancer Research Studies Oncology 2 works
- 7 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
- 8 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 9 Tracheal and airway disorders Pulmonary and Respiratory Medicine 2 works
- 10 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hyogo Prefectural Cancer Center's research output changed?
Output in 2018–2022 was 17% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Akashi
- Akashi Medical Center
- National Institute of Technology, Akashi College
- Akashi Municipal City Hospital
- Hyogo Ion Beam Medical Center
- Ohnishi Neurological Center
- Kobe University of Fashion and Design
- Seikow Chemical Engineering and Machinery (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.